论文信息 - Abstract A1: Phase 1 study of PF-03446962, a fully human mAb against activin receptor-like kinase 1 (ALK 1), a TGFβ receptor involved in tumor angiogenesis. - 字舞流文

Abstract A1: Phase 1 study of PF-03446962, a fully human mAb against activin receptor-like kinase 1 (ALK 1), a TGFβ receptor involved in tumor angiogenesis.

J. Berlin | H. Borghaei | W. Levin | A. Abbattista | L. Goff | R. Cohen | F. Braud | C. Noberasco | E. Wang | C. G. Stampino | H. Dan